Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects

Clinical trial NCT00551031 · COMPLETED

Trial details

NCT number: NCT00551031
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Myxovirus Infection

Start date: 2007-10-01
Primary completion: 2008-06-01
Enrollment: 2098

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.